
K.S.B Pharmaceuticals (India) Private Limited
About K.S.B Pharmaceuticals (India) Private Limited
Data last updated:
K.S.B Pharmaceuticals (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 04 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC372706.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tarun Kumar and Usha Athwal.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 17 – D A Block, Tilak Nagar, New Delhi, Delhi, India – 110018.
As per the financials filed for FY 2023, the company reported a revenue of ₹27.26 Lakh, a growth of 63% compared to the previous year. For the same year it recorded a net loss of ₹5.29 Lakh (net margin -19.4%) and EBITDA of -₹5.29 Lakh (EBITDA margin -19.4%).
Company details
Contact details
K.S.B Pharmaceuticals (India) Private Limited's registered office is in New Delhi, Delhi.
- Registered Address17 – D A Block, Tilak Nagar, New Delhi, Delhi, India – 110018
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of K.S.B Pharmaceuticals (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of K.S.B Pharmaceuticals (India) Private Limited, buy the company report.
Financials of K.S.B Pharmaceuticals (India) Private Limited
FY 2023 filings availableK.S.B Pharmaceuticals (India) Private Limited reported revenue of ₹27.26 Lakh (up 63% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 63% in the latest year. EBITDA fell 447% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹5.29 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹5.29 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -19.4% | ||
| Net Profit Margin | -19.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of K.S.B Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of K.S.B Pharmaceuticals (India) Private Limited
K.S.B Pharmaceuticals (India) has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarun Kumar Also directs: Zepsilon Healthcare Private Limited | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
| Usha Athwal | Director | 09 Dec 2023 | 2 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving K.S.B Pharmaceuticals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for K.S.B Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for K.S.B Pharmaceuticals (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
K.S.B Pharmaceuticals (India) Private Limited has 10 board changes on record since 2020: 6 appointments and 4 cessations. The latest: Saroj Sahni ceased to be Additional Director on 31 Aug 2024.
1 earlier event is in the company report.
Frequently asked questions
K.S.B Pharmaceuticals (India) is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 04 November 2020 (6+ years old) and is registered under CIN U51909DL2020PTC372706.
K.S.B Pharmaceuticals (India) has 2 current directors:
- Tarun Kumar - Director
- Usha Athwal - Director
The latest financial statements of K.S.B Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of K.S.B Pharmaceuticals (India) is U51909DL2020PTC372706. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
K.S.B Pharmaceuticals (India) was incorporated on 04 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Saroj Sahni ceased to be Additional Director on 31 Aug 2024. Raj Kishore Sah ceased to be Director on 09 Dec 2023. Saroj Sahni was appointed as Additional Director on 09 Dec 2023. K.S.B Pharmaceuticals (India) has 10 board changes on record in total.
The registered office of K.S.B Pharmaceuticals (India) is at 17 – D A Block, Tilak Nagar, New Delhi, Delhi, India – 110018.
K.S.B Pharmaceuticals (India) operates in the trading industry, in the specialty segment.
K.S.B Pharmaceuticals (India) can be reached at its registered office: 17 – D A Block, Tilak Nagar, New Delhi, Delhi, India – 110018.
K.S.B Pharmaceuticals (India) is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

